Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04378777 · ClinicalTrials.gov registry record
Immunophenotyping Assessment in a COVID-19 Cohort
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 1,227
- Enrollment target
NCT04378777 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 1,227 participants.
The verdict
NCT04378777 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 1,227 participants
- Enrollment target
Study Summary
This surveillance study will collect detailed clinical, laboratory, and radiographic data in coordination with biologic sampling of blood and respiratory secretions and viral shedding in nasal secretions in order to identify immunophenotypic and genomic features of COVID-19 -related susceptibility and/or progression. The aim: for the results obtained from this study to assist in generating hypotheses for effective host-directed therapeutic interventions, to help to prioritize proposals for such interventions, and/or optimize timing for administration of host-response directed therapeutics.
Interventions
- PROCEDURE Biological sample collection
- PROCEDURE Data Collection: Clinical Care Assessments
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,227 participants |
| Start Date | 2020-05-01 |
| Est. Completion | 2022-04-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04378777
The ClinicalTrials.gov registry entry for NCT04378777 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,227 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Biological sample collection is the first listed.
NCT04378777 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04378777 about?
NCT04378777 is a clinical study titled "Immunophenotyping Assessment in a COVID-19 Cohort". This surveillance study will collect detailed clinical, laboratory, and radiographic data in coordination with biologic sampling of blood and respiratory secretions and viral shedding in nasal secretions in order to identify immunophenotypic and genomic features of COVID-19 -related susceptibility a...
What is the current status of trial NCT04378777?
This trial is currently completed. The enrollment target is 1,227 participants. The study started on 2020-05-01. Estimated completion is 2022-04-21.
What interventions are being tested in trial NCT04378777?
The interventions under investigation include: Biological sample collection (PROCEDURE), Data Collection: Clinical Care Assessments (PROCEDURE).
Who is sponsoring clinical trial NCT04378777?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.